IMAB
Price
$3.49
Change
-$0.03 (-0.85%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
405.74M
48 days until earnings call
TPST
Price
$9.50
Change
+$0.19 (+2.04%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
41.34M
Interact to see
Advertisement

IMAB vs TPST

Header iconIMAB vs TPST Comparison
Open Charts IMAB vs TPSTBanner chart's image
I-MAB
Price$3.49
Change-$0.03 (-0.85%)
Volume$2.07K
Capitalization405.74M
Tempest Therapeutics
Price$9.50
Change+$0.19 (+2.04%)
Volume$100
Capitalization41.34M
IMAB vs TPST Comparison Chart in %
Loading...
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMAB vs. TPST commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMAB is a Buy and TPST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (IMAB: $3.49 vs. TPST: $9.50)
Brand notoriety: IMAB and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMAB: 6% vs. TPST: 10%
Market capitalization -- IMAB: $405.74M vs. TPST: $41.34M
IMAB [@Biotechnology] is valued at $405.74M. TPST’s [@Biotechnology] market capitalization is $41.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMAB’s FA Score shows that 0 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • IMAB’s FA Score: 0 green, 5 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMAB and TPST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMAB’s TA Score shows that 2 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • IMAB’s TA Score: 2 bullish, 5 bearish.
  • TPST’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, TPST is a better buy in the short-term than IMAB.

Price Growth

IMAB (@Biotechnology) experienced а -7.92% price change this week, while TPST (@Biotechnology) price change was -6.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

IMAB is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMAB($406M) has a higher market cap than TPST($41.3M). IMAB YTD gains are higher at: 314.118 vs. TPST (-12.430). IMAB has higher annual earnings (EBITDA): -36.89M vs. TPST (-42.04M). IMAB has more cash in the bank: 166M vs. TPST (14.3M). IMAB has less debt than TPST: IMAB (3.48M) vs TPST (8.66M). IMAB (0) and TPST (0) have equivalent revenues.
IMABTPSTIMAB / TPST
Capitalization406M41.3M983%
EBITDA-36.89M-42.04M88%
Gain YTD314.118-12.430-2,527%
P/E RatioN/AN/A-
Revenue00-
Total Cash166M14.3M1,161%
Total Debt3.48M8.66M40%
FUNDAMENTALS RATINGS
TPST: Fundamental Ratings
TPST
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMABTPST
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCCOY0.60N/A
N/A
BICO GROUP AB
VPIM1.45N/A
N/A
Vitality Prime Inc.
FGSKX59.36-0.42
-0.70%
Federated Hermes MDT Mid Cap Growth R6
CSIOY83.60-1.00
-1.18%
Casio Computer Co., Ltd.
ADDHY16.50-0.80
-4.62%
Addtech AB

IMAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMAB has been loosely correlated with INDP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IMAB jumps, then INDP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMAB
1D Price
Change %
IMAB100%
-1.12%
INDP - IMAB
38%
Loosely correlated
+10.81%
LYRA - IMAB
34%
Loosely correlated
-2.15%
RPRX - IMAB
31%
Poorly correlated
-2.43%
TPST - IMAB
29%
Poorly correlated
+1.20%
APLS - IMAB
27%
Poorly correlated
-2.37%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
+2.04%
PHIO - TPST
51%
Loosely correlated
+0.15%
ABCZF - TPST
49%
Loosely correlated
N/A
LXEO - TPST
41%
Loosely correlated
+4.15%
RLAY - TPST
40%
Loosely correlated
+18.04%
ARCT - TPST
38%
Loosely correlated
+9.11%
More